Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BOLT BIOTHERAPEUTICS INC
About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in half-life-extended multispecific antibodies designed to deliver therapies. Through the proprietary INSPIRE platform, the Company combines complementary therapeutic mechanisms in fully IgG-based molecules designed for efficacy and extended exposure. Its lead program, PRA-216, is a novel IL-4Ra/TSLP bispecific antibody in Phase II development in asthma, chronic obstructive pulmonary disease, and atopic dermatitis, with a fourth Phase II study planned in eosinophilic esophagitis. In addition to PRA-216, the Company is advancing a wholly owned pipeline of additional INSPIRE-based multispecific programs across diseases with significant unmet need. Its second program is an IL-31 containing bispecific antibody being developed initially for atopic dermatitis. The Company is open to various partnering programs, including BDC-3042: P2-ready Dectin-2 Agonist mA, Preclinical CEA ISAC and Preclinical PD-L1 ISAC.
Find out what a historical investment in BOLT BIOTHERAPEUTICS INC would be worth today using our BOLT stock calculator.
Market Capitalisation
$16.47M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
82.98K
High today
$6.60
Low today
$6.28
Open price
$6.34
52-week high
$7.78
52-week low
$3.10
Ready to start your investing journey with Stake?
Open an accountHow do I buy BOLT shares in Australia?
Buying BOLT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BOLT BIOTHERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BOLT
What is the ticker symbol of BOLT BIOTHERAPEUTICS INC?
The ticker symbol for BOLT BIOTHERAPEUTICS INC is BOLT.
How much is one share of BOLT?
One share of BOLT is valued at $6.55 as of 29 October 2026.
What is the market capitalisation of BOLT BIOTHERAPEUTICS INC BOLT?
As of 29 October 2026 BOLT BIOTHERAPEUTICS INC has a market cap of $16.47M.
What is the 52-week high for BOLT BIOTHERAPEUTICS INC stock?
The BOLT BIOTHERAPEUTICS INC 52-week high stock price is $7.78.
What is the 52-week low for BOLT BIOTHERAPEUTICS INC stock?
The BOLT BIOTHERAPEUTICS INC 52-week low stock price is $3.10.
Can I buy BOLT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BOLT shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BOLT on Stake
- Buy BOLT from US$3 brokerage
- Invest in 11,000+ U.S. stocks and ETFs
- Own a slice of BOLT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BOLT related stocks